Nicoya Lifesciences, a leading biotechnology company, has raised $2 million in its latest financing round. The round was led by Ripple Ventures and GTAN, with participation from MaRS IAF, BDC, Garage Capital, Angel One, Maple Leaf Angels, Innovation Grade Ventures, the Laurier Startup Fund, the